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Objective: This report describes the early and midterm results after intraoperative
radiofrequency ablation of atrial fibrillation for patients with isolated chronic atrial
fibrillation or atrial fibrillation in combination with additional valvular and nonval-
vular cardiac diseases.
Methods: From August 1998 to March 2001, a total of 234 patients with chronic
atrial fibrillation underwent isolated intraoperative radiofrequency ablation alone
(n  74, 31.6%) or in combination with other cardiac procedures, such as mitral
valve reconstruction (n  57, 24.4%), mitral valve replacement (n  38, 16.2%),
aortic valve replacement (n  11, 5.1%), coronary artery bypass grafting (n  8,
5.0%), or a combination of the last with other cardiac procedures (n  46, 19.7%).
In all cases anatomic reentrant circuits confined within the left atrium were elimi-
nated by placing contiguous lesion lines involving the mitral anulus and the orifices
of the pulmonary veins through the use of radiofrequency energy application
(exposure time, 20 seconds). A median sternotomy was used in 101 cases (43.2%),
and video assistance through a right lateral minithoracotomy was used in 133 cases
(56.8%).
Results: A total of 188 patients (83.9%) were discharged in sinus rhythm, 17
patients (7.6%) had atrial fibrillation, and 19 patients (8.5%) had atypical flutter.
Pacemakers were implanted in 23 patients (9.8%). There were 10 in-hospital deaths
(4.2%), and 30-day mortality was 5 patients (2.1%). In 3 cases (1.3%) an atrio-
esophageal fistula developed, necessitating surgical repair. Six months’ follow-up
was complete for 122 (61.0%) of 200 patients, with 99 patients still in stable sinus
rhythm (81.1%, 95% confidence interval 73.1%-89.9%). Twelve months’ follow-up
was complete for 80 (90.9%) of 88 patients, with 58 patients still in sinus rhythm
(72.5%, 95% confidence interval 61.3%-83.2%).
Conclusions: Intraoperative radiofrequency ablation is a curative procedure for
chronic atrial fibrillation. It is technically less challenging than the maze procedure
and can be applied through a minimally invasive approach. Protection of the
esophagus seems mandatory to avoid the deleterious complication of a left atrio-
esophageal fistula, such as was observed in 3 cases.
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Atrial fibrillation (AF) is the most commonsustained arrhythmia and is associatedwith substantial morbidity and mortali-ty.1,2 A number of interventional conceptsthat are based on eliminating the initiatingtrigger or modifying the maintaining sub-
strate have evolved within the past 2 decades. Catheter-
based interventions for ventricular rate control, such as
atrioventricular junction ablation or atrioventricular nodal
modification, have the disadvantage of persistence of AF.3
Surgical techniques such as the corridor operation4 or left
atrial isolation5 effectively restore sinus rhythm but not
biatrial transport function. The maze procedure6,7 and the
so-called radial approach,8,9 although highly effective, are
technically demanding and time consuming, and they there-
fore have not found widespread application outside a few
centers of excellence.
Percutaneous radiofrequency ablation to induce right
atrial lesions for the treatment of paroxysmal AF has shown
to be feasible.10 However, the reported success rates were
only 13% if only the right atrium was ablated and 44% to
47% if additional lines were made in the left atrium, poten-
tially replicating the maze concept.11,12 For the treatment of
idiopathic AF, catheter-based radiofrequency ablation has
shown poor results. One hundred percent of all patients who
underwent ablation confined to the left atrium had recur-
rence of AF13 as a result of technical difficulties that pre-
vented the creation of the intended left atrial line pattern. In
right atrial ablation, recurrence was 94% despite creation of
complete line patterns in the right atrium in half of the
treated patients.13 In addition to excessive procedural times
for percutaneous radiofrequency ablation of 5 to 10
hours,12,13 there are several procedure-related complications
such as cardiac tamponade, stroke, thromboembolism, and
pulmonary vein stenosis.11-14
Recently, the concept of surgical elimination of anatom-
ically determined left atrial “anchor” reentrant circuits by
induction of contiguous left atrial lesion lines between the
pulmonary veins and the mitral anulus with radiofrequency
energy has been introduced. Under direct vision complete-
ness of the lesion line has been verified, with short proce-
dure times.15 In this article we describe our experience and
early and midterm outcomes in 234 patients with chronic
AF who underwent intraoperative radiofrequency ablation
of AF, either isolated or in combination with other cardiac
procedures.
Patient Characteristics
From August 1998 to March 2001, a total of 234 patients
were treated with intraoperative radiofrequency ablation of
AF at our institution. Primary indication for intraoperative
radiofrequency ablation was chronic persistent AF or symp-
tomatic chronic paroxysmal AF refractory to medical treat-
ment. There were 143 men and 91 women, with a mean age
of 62.8 11.0 years. The average duration of AF was 7.8
5.2 years. Twenty-nine patients (12.4%) had a reduced left
ventricular ejection fraction of less than 35%, and of these
4 patients underwent (1.7%) reoperation. Mean left ventric-
ular function was 53.7%  13.9%, and mean left atrial
diameter was 58.0  11.5  49.3  10.9 mm. Associated
morphologic cardiac disease included mitral stenosis (n 
52, 22.2%), mitral valve regurgitation (n  94, 40.2%),
severe tricuspid regurgitation (n  18, 7.7%), atrial septal
defect (n  4, 1.7%), coronary artery disease (n  34,
14.5%), aortic valve stenosis (n  31, 13.2%), aortic valve
insufficiency (n  1, 0.4%), and dilated cardiomyopathy
(n  8, 3.4%). Sixteen patients (6.8%) with AF already had
permanent pacemaker implantation before intraoperative ra-
diofrequency ablation because of symptomatic bradycardia
(n  6, 2.6%) or total atrioventricular block (n  10, 4.3%)
before the operation.
Surgical Procedure
Patients were operated on through a median sternotomy
(n  101, 43.2%) or through a minimally invasive surgical
approach through a right lateral minithoracotomy (n  133,
56.8%). Categorizing all patients into groups determined by
surgical procedure and approach, 3 groups were defined:
intraoperative radiofrequency ablation as primary indication
for operation and performed minimally invasively (group A,
n  74 patients), ablation and mitral valve surgery with
minimally invasive technique or conventional technique
(group B, n  95), and ablation combined with other
cardiac procedures in a conventional technique (group C,
n  65; Table 1).
In the sternotomy group standard aortic and right atrial
cannulation was performed and antegrade crystalloid or
cold blood cardioplegia was administered. After opening of
the left atrium, intraoperative radiofrequency ablation of AF
was performed as described here.
In the minimally invasive group a right lateral minitho-
racotomy (4-6 cm) in the fourth intercostal space was per-
formed and bypass was established by femorofemoral can-
nulation. For arterial cannulation a 16F to 20F arterial
cannula was used (Baxter Healthcare Corporation, Edwards
Division, Irvine, Calif). Venous drainage was achieved with
a 22F femoral cannula (Heartport, Inc, Redwood City,
Calif) and a 16F arterial cannula inserted in the right inter-
nal jugular vein (Baxter Edwards) with enhanced venous
drainage with vacuum assistance. Direct aortic clamping
was performed with a transthoracic clamp (Chitwood
clamp; Scanlan International, St Paul, Minn) inserted per-
cutaneously in the second intercostal space. Antegrade cold
crystalloid cardioplegia or cold blood cardioplegia was ap-
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plied for myocardial protection by puncture of the ascend-
ing aorta. After exposure of the left atrium, it was incised
parallel to the interatrial groove anterior to the right pulmo-
nary veins, thus allowing direct access to the mitral anulus
as well as to the orifices of the pulmonary veins. No further
atriotomy was performed, and the right atrium was not
opened except in case of concomitant tricuspid valve repair.
The left atrial appendage was not excised or ligated. Con-
tinuous carbon dioxide insufflation was used to evacuate air
from the operative field.
Radiofrequency Ablation (Figure 1)
For intraoperative radiofrequency ablation a 10-mm
T-shaped ablation probe (Osypka GmbH, Grenzach-
Wyhlen, Germany) was used. Alternating current was de-
livered by a generator (350 kHz, modified HAT 200S;
Osypka) with maximum energy levels of 50 W in a unipolar
mode between the tip electrode and a 10  16-cm external
backplate electrode to achieve a temperature of 60°C at its
tip. Power, impedance, and tip temperature were monitored
continuously throughout the procedure. With assurance of
catheter stability, well-visualized endocardial lesion lines at
the previously selected catheter tip temperature were placed,
and the ablation probe was stepwise withdrawn after 20
seconds. A contiguous lesion line extending from the infe-
rior aspect of the mitral anulus to the left lower pulmonary
vein was performed. Through a second line the left lower
and upper pulmonary vein orifices were connected. Through
a third line the left and right upper pulmonary veins were
connected. Finally, the right upper and left lower pulmonary
vein orifices were connected. An additional line at the left
atrial roof was at last extended to the surgical incision. The
number of applications performed depended on the size of
the left atrium. The ablation procedure was always per-
formed before any other surgical procedures were per-
formed.
Postoperative Management and Follow-Up
After the operation all patients were monitored daily with
12-lead electrocardiographic recordings for the first 5 post-
operative days. In addition, two 24-hour electrocardio-
graphic recordings were performed for every patient. In
cases of postoperative AF that occurred within 10 days after
the operation, electric cardioversion was performed either
alone or in combination with the administration of amioda-
rone, flecainide, or sotalol. Patients in stable sinus rhythm
(as defined by the presence of a P wave) without additional
antiarrhythmic therapy received anticoagulation for 3
months; all patients who were receiving additional antiar-
rhythmic drugs received anticoagulation for 6 months. Pa-
tients were evaluated on discharge and 6 months thereafter
by a 12-lead electrocardiography and 24-hour Holter mon-
itoring. Follow-up was considered complete for patients
seen at the 6- and 12-month follow-up examinations. On the
basis of these data, a 95% confidence interval (CI) was
calculated.
Statistical Analysis
Continuous variables are expressed as mean  SD. A 95%
CI for the probability of success was calculated by the
Clopper-Pearson method for dichotomous data, which takes
into account the number of examinations, thus yielding
probability intervals for sinus rhythm at discharge and at 6
and 12 months’ follow-up. Statistical calculations were per-
formed with StatXact (release 4.0; Cytel Software Corpo-
ration, Cambridge, Mass).
Results
Mean operating time was 167.1  53.3 minutes, mean
duration of cardiopulmonary bypass was 114.1  38.1
minutes, mean crossclamp time was 69.0  28.4 minutes,
and mean procedural time for ablation was 17.2  8.1
minutes. On admission to the intensive care unit, patients
were either in spontaneous sinus rhythm (83.3%) or elec-
trically paced in atrioventricular universal (DDD) or atrial
inhibited (AAI) mode (16.6%).
Early Recurrence of Atrial Fibrillation and
Perioperative Arrhythmias
Perioperative atrial arrhythmias were observed in 143 pa-
tients (61.1%) as supraventricular tachyarrhythmia (n  71,
30.3%), atypical flutter (n 112, 47.9%), or both. A total of
133 patients were treated successfully with one or more
cardioversions alone (56.8%) or in combination with ami-
odarone (n  92, 39.3%), flecainide (n  30, 12.8%), or
sotalol (n  21, 8.9%). Ninety (38.5%) patients had to be
Figure 1. Intraoperative radiofrequency ablation of AF: lesion
concept. MV, mitral valve; MA, mitral anulus; APP, appendage;
LUPV, left upper pulmonary vein; LLPV, left lower pulmonary vein;
RUPV, right upper pulmonary vein; RLPV, right lower pulmonary
vein.
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monitored for more than 3 days in the intermediate care unit
because of unstable cardiac rhythms.
Discharge
Of the patients discharged (n  224), sinus rhythm was
established in 188 patients (83.9%); 19 patients (8.5%) were
discharged with atypical flutter, and 17 patients (7.6%) were
discharged with persisting AF.
In a comparison by groups, restoration of sinus rhythm
was successful in 91.9% of cases in group A (n  68),
76.8% of cases in group B (n  73), and 72.3% of cases in
group C (n  47). In group A 1.4% of the patients (n 
1/74) were discharged with atypical flutter, as compared
with 5.3% in group B (n  5/95) and 6.2% in group C (n 
4/65). Atypical flutter was observed in 5.4% of patients in
group A (n  4/74), 12.6% of patients in group B (n 
12/95), and 4.6% of patients in group C (n  3/65). In 23
cases (9.8%) a permanent pacemaker implantation was
needed after the operation because of sinus bradycardia,
with or without sinus arrest or atrioventricular dissociation.
Six Months’ and 12 Months’ Follow-up (Table 2)
After 6 months 97.4% (37/38) of group A, 77.8% (42/54) of
group B, and 66.7% (20/30) of group C were in sinus
rhythm, respectively. Sinus rhythm with intermittent AF or
atypical flutter was observed in 2.6% (1/38) in group A,
11.1% (6/54) in group B, and 3.3% (1/30) in group C.
Atypical flutter was seen in 5.6% (3/54) in group B and
3.3% (1/30) in group C. Six months’ follow-up was com-
plete in 122 of 200 patients (61.0%) with 99 patients still in
stable sinus rhythm (81.1% [95%, CI: 73.1-89.9]). In 2
patients an isthmus ablation was performed due to atrial
flutter (1.8%); 3 patients required an additional 2-chamber
pacemaker implantation (2.8%). One patient required reop-
eration after initial mitral valve reconstruction due to recur-
rent mitral valve regurgitation. Two patients (0.8%) had a
cerebral stroke during the follow-up period.
After 12 months 93.8% (15/16) of group A, 70.0%
(30/43) of group B, and 61.9% (13/21) of group C were in
sinus rhythm, respectively.
Sinus rhythm with intermittent AF or atypical flutter was
observed in 6.3% (1/16) in group A, 2.3% (1/43) in group B,
and 4.8% (1/21) in group C. Atypical flutter was observed in
7.0% (3/43) in group B and 4.8% (1/21) in group C. Twelve
months’ follow-up was complete in 80 of 88 patients
(90.9%) with 58 patients still in sinus rhythm (72.5% [95%
CI: 61.3%-83.2%]). One patient required an additional
2-chamber pacemaker implantation (0.4%) and 1 patient
(0.4%) had a cerebral stroke during the follow-up period.
Three patients had died after 12 months, 2 of unknown
cause and 1 of a cerebral stroke.
Complications, Morbidity, and Mortality
Two patients (0.8%) required conversion from minithora-
cotomy to median sternotomy. Reexploration for bleeding
was required in 18 patients (6.8%), and 6 patients required
postoperative circulatory support such as intra-aortic bal-
loon pumping (n  5, 2.1%) or extracorporeal membrane
oxygenation (n  2, 0.8%). Two patients (0.8%) required
reoperation within 5 days after the initial operation: 1 pa-
tient had mitral valve regurgitation after initial reconstruc-
tion and 1 patient had a prosthesis infection. Two patients
(0.8%) had sternal infections, 1 patient (0.4%) showed
perioperative ischemia caused by stenosis of the circumflex
artery, which was successfully treated by angioplasty and
stent implantation, and 3 patients (1.3%) had cerebral
strokes after the operation. Three patients (1.2%) had atrio-
esophageal perforations, and 2 of them had successful re-
operations. One patient (0.4%) died of severe cerebral in-
farction, and 1 patient (0.4%) had an inguinal infection after
femorofemoral cannulation.
Mortality was 15 patients (6.4%); 10 patients (4.2%)
died during postoperative hospitalization, with a mean hos-
pitalization time of 33.8 days (range 10-96 days). Two
patients (0.8%) died of adult respiratory distress syndrome,
1 patient died (0.4%) of pulmonary embolism, 3 patients
(1.3%) died of sepsis, 2 patients (0.8%) died of low cardiac
output, 1 patient (0.4%) died of stroke, and 1 patient (0.4%)
died of unknown causes.
TABLE 1. Patient characteristics
Group A (n  74) Group B (n  95) Group C (n  65) Total (n  234)
Age (y, mean  SD) 53.10 9.8 66.20 11.80 69.10 6.2 62.86 11.00
Sex ratio (male/female) 57/17 43/52 43/22 143/91
AF duration (y, mean  SD) 7.5 6.9 6.6 6.1 8.2 5.2 7.8 5.2
Left ventricular ejection
fraction (%, mean  SD)
62.3 9.5 51.9 13.6 50.73 13.7 53.73 13.92
Left atrial diameter (mm,
mean  SD)
50.2 7.6 65.25 10.5 59.6 11.8 58.03 11.53
40.6 7.6 56.0 10.1 49.7 10.3 49.32 10.95
Group A, Intraoperative radiofrequency ablation of AF as primary indication with surgery through minimally invasive technique; group B, intraoperative
radiofrequency ablation of AF and mitral valve surgery; group C, intraoperative radiofrequency ablation of AF combined with other surgical procedures.
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All deaths but 1 (of cerebral air embolism after atrio-
esophageal infarction) were related to the high-risk profile
of the underlying cardiac disease and not to the intraoper-
ative radiofrequency ablation procedure. There were no
deaths among the patients treated for isolated chronic or
paroxysmal AF. Atrioesophageal perforation was the only
procedure-related complication, and in 1 case (0.4%) it was
lethal.
Discussion
The maze procedure was introduced by Cox and associ-
ates16 in 1991 as a curative therapy for patients with chronic
AF. Depending on inclusion criteria, restoration of sinus
rhythm is possible for 65% to 93% of the patients.6,17-19
Reported mortality for combined operations and the need
for postoperative pacemaker implantation are in the range of
0% to 5% and 2% to 14%, respectively.19 Several attempts
have been made to develop simpler but equally effective
surgical treatment strategies, but so far none has exceeded
the good results of the original maze III procedure.5,8,20
In 1997 Patwardhan and colleagues21 reported the use of
intraoperative radiofrequency coagulation to induce contig-
uous lesion lines to replace the right and left atrial incisions
of the maze III procedure. A combined approach with
surgical incisions and radiofrequency-induced linear lesions
was introduced by Sie and coworkers,22 reducing the oper-
ating time for the maze procedure. Melo and associates23
used radiofrequency-induced contiguous left atrial lesion
lines around the pulmonary veins for surgical pulmonary
vein isolation and achieved restoration of sinus rhythm in
71% of their cases. A similar approach of surgical isolation
of the pulmonary veins with cryoablation was recently
reported by Sueda and colleagues.24 At a mean follow-up of
8 months, 83% of their patients (n  12) were in sinus
rhythm.
Whereas these strategies have aimed at isolating the
focus for AF, our strategy for intraoperative radiofrequency
ablation of AF follows the concept of elimination of ana-
tomically determined left atrial “anchor” reentrant circuits
by induction of contiguous left atrial lesion lines between
the pulmonary veins and the mitral anulus with radiofre-
quency energy.25,26 This concept is based on the hypothesis
that anatomically defined left atrial reentrant circuits are
crucial for the perpetuation of AF. These circuits anchor
around the pulmonary vein orifices when functional reen-
trant circuits have been extinguished, thereby ensuring
maintenance of AF and preventing its termination.27
An initial study (n  12) demonstrated that a restricted
approach of elimination of anatomically defined anchor
reentrant circuits within the left atrium prevented chronic
AF in more than 80% of patients with mitral valve disease
and chronic AF.27 Further modifications of the technique
have allowed its routine application through a minimally
invasive approach through a right anterolateral minithora-
cotomy,28 which is currently the access of choice for iso-
lated mitral valve surgery at our institution.29,30 The patients
included in this study represent an unselected group of
patients with a variety of cardiac diseases who underwent
intraoperative radiofrequency ablation, either alone or in
combination with additional cardiac procedures. Morbidity,
mortality, freedom from AF at early and midterm follow-up,
and the need for postoperative pacemaker implantation are
comparable to the results of the maze III procedure.
Whereas the maze III procedure is a relatively rare opera-
tion (76 patients in a 5-year period at one institution31 and
346 patients in a 12-year period at the leading center32), the
TABLE 2. Discharge, 6 months, and 12 months of follow-up
Group A: IRAAF as primary indication with surgery via minimally invasive technique
Discharge SR 91.9% (68/74) SR/AFL — AFL 1.4% (1/74)
Six months SR 97.4% (37/38) SR/AFL 2.6% (1/38) AFL —
Twelve months SR 93.8% (15/16) SR/AFL 6.3% (1/16) AFL —
Group B: IRAAF and mitral valve surgery in minimally invasive technique
Discharge SR 76.8% (73/95) AR/AFL — AFL 12.6% (12/95)
Six months SR 77.8% (42/54) SR/AF 11.1% (6/54) AFL 5.6% (3/54)
Twelve months SR 69.2% (30/43) SR/AF 2.3% (1/43) AFL 7.0% (3/43)
Group C: IRAAF combined with other surgical procedures
Discharge SR 72.3% (47/65) AFL 4.6% (3/65)
Six months SR 66.7% (20/30) SR/AFL 3.3% (1/30) AFL 3.3% (1/30)
Twelve months SR 61.9% (13/21) SR/AFL 4.8% (1/21) AFL 4.8% (1/21)
Follow-up:
Six months SR 81.1% (99/122) [95% CI: 73.1%-89.9%]
Twelve months SR 72.5% (58/80) [95% CI: 61.3%-83.2%]
SR, Sinus rhythm; SR/AFL, SR with intermittent atrial fibrillation or atypical flutter; AFL, atypical flutter; LA, left atrial diameter.
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ease of application of intraoperative radiofrequency ablation
allowed its use in 234 patients in a 2-year period, with about
half of the patients operated on in a minimally invasive
fashion. The avoidance of a sternotomy has largely in-
creased patient acceptance of surgical treatment for isolated
AF and is the major reason for increased patient referral for
antiarrhythmic surgical treatment. Relative to the maze pro-
cedure, aortic crossclamp and cardiopulmonary bypass
times are shorter, and postoperative diuretic treatment for
atrial natriuretic peptide deficiency is not necessary.33 The
limited left atrial approach will, of course, not eliminate
atrial flutter originating from the right atrium, as the maze
procedure does. As our data in group A clearly demonstrate,
however, this approach is highly effective to treat stand-
alone AF. Postoperative atrial flutter was therefore not en-
countered as recurrence of AF among our patients and was
subsequently treated successfully by catheter techniques in
some cases.
There are, however, new procedure-related complica-
tions that require careful application of this technique. In 3
cases we found atrioesophageal fistulas that were seen after
an initial uncomplicated recovery at postoperative intervals
of 3 and 6 days, with repetitive neurologic deficits caused by
multiple air embolisms in 2 patients. Both of the latter
patients underwent reoperation for repair of the esophagus
and left atrium. In another case sudden onset of upper
gastrointestinal tract bleeding necessitated gastroscopy. Af-
ter insufflation of carbon dioxide, massive cerebral air em-
bolism occurred, from which the patient died. All other
deaths (n  9) were not procedure related. Although the
exact mechanism of esophageal injury after intraoperative
radiofrequency ablation of AF and subsequent transesoph-
ageal echocardiographic studies is still speculative, the most
likely cause of this detrimental sequel is a thermal injury
during radiofrequency application, in combination with me-
chanical trauma induced by the echocardiographic probes.
In all cases a transesophageal echocardiography probe was
in place before and 3 to 6 days after the operation to study
left atrial contractility, and this may have caused additional
mechanical irritation. Since the first complication occurred,
we no longer leave the probe in the esophagus during
ablation and have switched to transthoracic echocardiogra-
phy during the early postoperative period. In addition, an
isolating scrub is placed into the sinus obliquus pericardii
behind the left atrial wall to prevent the passage of electric
and thermal energy through the esophagus. Esophageal per-
forations have been observed by others with different ra-
diofrequency catheter devices and also in some cases after
transesophageal echocardiographic studies alone. This com-
plication needs further investigation.
Several studies with percutaneous radiofrequency cathe-
ter ablation within the right atrium showed an extremely
limited efficacy, indicating that induction of right atrial
lesions is not sufficient to cure AF. The lesion geometries
that have been applied percutaneously so far seem to be
empirically derived, and no successful lesion geometry con-
cept for percutaneous application has been validated. Fail-
ure to induce continuous lesion lines necessary for proper
isolation has led to the poor results reported for catheter-
based left atrial ablation. In addition to a disappointing
100% recurrence rate, complications of catheter-based in-
terventions included cerebral infarction, tamponade neces-
sitating immediate pericardiocentesis, retroperitoneal hema-
toma, and pneumothorax, as well as pericardial effusions
and pacemaker implantations.13
Because of the poor results of catheter-based interven-
tions for the treatment of AF and in the light of the relatively
small numbers of maze procedures that are performed, the
concept of intraoperative radiofrequency ablation of AF
seems to present a promising alternative. The necessity of
avoiding procedure-related complications is obvious from
the data presented here, but now that the mechanism of
injury is known, means of prevention can be developed. The
question whether different radiofrequency catheter probes
or other energy sources, such as microwave and cryoabla-
tion, will demonstrate better surgical results requires future
study.
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Discussion
Dr Michael Argenziano (New York, NY). In this article Mohr
and associates reported their experience with a modified left atrial
radiofrequency ablation procedure for patients with chronic AF,
performed either as a primary procedure or concomitant with
coronary artery bypass grafting or valvular surgery. Despite the
lack of randomization and absence of control groups, Mohr and
associates are to be congratulated on this large clinical series,
which demonstrates the feasibility and efficacy of surgical endo-
cardial radiofrequency ablation of AF.
In addition, they are to be commended for advancing the
development of this field in two important ways. First, they have
demonstrated the feasibility of performing left atrial radiofre-
quency ablation as a primary procedure, with AF as the sole
indication. It is interesting to note, in fact, that in this study
ablations performed solely for AF actually resulted in higher
midterm success rates than did ablations performed in combination
with other cardiac operations. Second, by performing most of their
procedures through small thoracotomy incisions, Mohr and asso-
ciates have taken a critical step toward the ultimate goal of a totally
minimally invasive surgical approach to the management of
chronic AF.
I have several comments and questions, Dr Mohr. Your method
of radiofrequency ablation is different from that used by our group
and many others in that you do not circumferentially isolate the
pulmonary veins and also do not electrically or mechanically
exclude the left atrial appendage. As we have reported, we make a
single encircling radiofrequency lesion around the pulmonary
veins and a lesion to the mitral anulus but also make a lesion
around the left atrial appendage and add a connecting line from
this lesion to the pulmonary vein isolation line. We do this to
exclude arrhythmogenic foci within the pulmonary veins and left
atrial appendage, and also to prevent arrhythmias caused by reen-
trant conduction around the base of the appendage. Despite the
differences in the techniques that we use, we have reported mid-
term success rates similar to those presented by you today for
patients undergoing concomitant cardiac procedures such as mitral
valve replacement. My first question is, how did you choose your
lesion set, and which components of this set if any do you think are
absolutely necessary for the reliable elimination of AF?
My second question relates to the handling of the left atrial
appendage. In our experience, with careful inspection thrombus is
often found within the appendage, even when it is not visualized
by transesophageal echocardiography. For this reason we routinely
ligate the appendage from within the atrium with a purse-string
suture. Why have you chosen to leave the appendage open? And
with regard to your patients who died of strokes, do you think it is
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possible that the source of embolization could have been the left
atrial appendage?
My third question relates to two specific complications that
occurred in your series: 3 atrioesophageal fistulas and 1 case of
circumflex artery stenosis. Presumably, as you suggest, these in-
juries were induced by the radiofrequency probe. However, it
seems unlikely to me that the application of radiofrequency energy
controlled to a maximum temperature of 60°C to 65°C for only 20
seconds would cause this degree of damage, because most other
authors have used higher target temperatures of 70°C to 80°C for
much longer burn times, as long as 2 minutes, without significant
injuries. Is it possible that the actual delivered temperature was
higher than that recorded by the probe, as might be the case with
continuous irrigation of the probe at the endocardial surface? Also,
was too much pressure exerted on the probe in certain areas,
perhaps because of inadequate exposure? To avoid these compli-
cations, we also routinely withdraw the transesophageal echocar-
diography probe at the time of radiofrequency delivery, and we
also administer retrograde cardioplegia during radiofrequency ap-
plication near the mitral anulus.
My next question is about your reference in your presentation
to potential prophylactic use of this operation. You did not mention
this in the article, but I presume that when you said prophylaxis,
for instance, in patients having atrial septal defect closure, you
meant that you actually applied this operation in patients who were
not in AF at the time of surgery. If that is not what you meant,
please clarify that.
Finally, although you mentioned that you performed echocar-
diographic evaluations to assess the effects of your operation on
atrial transport function, you did not actually report those data.
What were your findings with respect to atrial transport function in
patients in whom you achieved electrocardiographic success?
I believe that this is a seminal contribution to this exciting field
of surgical interest.
Dr Mohr. With respect to the prophylactic operations, these
were patients who had AF but did not have severe symptoms. They
were coming for an atrial septal defect closure or an autograft
replacement and were in sinus rhythm, without AF at the time of
the operation. So we considered this a prophylactic procedure. The
same is true for the coronary artery bypass grafting operations.
The next question was about aortoesophageal fistulas. Actually,
we are not the only ones who have observed aortoesophageal
fistulas. They have also occurred with the other probe, the radio-
frequency probe that your group is using. This has not been
reported, but if you talk to some groups, you will discover that it
has happened. I just wanted to draw attention to that. I truly believe
that the radiofrequency itself may have some injury to the esoph-
agus, with the mechanical push of the transesophageal echocar-
diographic probe, which was used after 1 week to evaluate left
atrial contraction, perhaps finally causing the perforation. This is
what I assume. I cannot tell you the reason.
With respect to the temperature, we have evaluated several
radiofrequency probes, including the probe that you are using. The
probe that you are using allows for a measurable temperature at the
epicardium within 3 seconds up to 65°C and then it shuts off,
whereas with the Boston Scientific probe it takes you up to 90
seconds to reach this epicardial temperature. This may well be why
you do not have that effect on the esophagus. On the other hand,
it does have an effect on continuous lines. If you look into the
worldwide results with the other probe, they are worse than with
our probe, because you are more likely to have a gap. At least we
have found that in our laboratory.
The left atrial appendage is, as far as we can tell, a major part
that helps in the contraction of the left atrium. If you cut it off, you
will have a problem as with the Cox maze procedure in that you
must continue diuretics all the time. You could sew the appendage
closed, but in our study protocol we decided not to do so, so that
we could measure the left atrial contractility also in the left atrial
appendage.
To answer the question about the left atrial contractility, pa-
tients with normally sized left atria had normal left atrial contrac-
tility. If you remember Miller’s scoring, it would be a score of 4.
Among patients who had dilated left atria that were downsized, the
left atrial contractility was relatively low at the beginning but had
recovered after 3 to 6 months.
Our lesion sets did not include the left atrial appendage. I think
that if you go to the electrophysiology meeting, it is the clear
opinion of the cardiologists that the left atrial appendage does not
play a role. Most of them localize the multifocal lesions in several
pulmonary veins and alongside to the roof and the mitral valve
anulus.
Finally, to answer the question about working only on the
pulmonary veins alone on both sides, as has been described by
some authors, I think that this misses an important connection to
the mitral valve. This is why you cannot do the procedure epicar-
dially. The connection to the mitral valve is essential, in our view.
Dr Niv Ad (Tel-Aviv, Israel). I have one question and a quick
comment. Looking at your results, especially for the patients in
whom the ablation was combined with mitral valve surgery, it is
clear that your success rate in abolishing AF is significantly lower
than the results reported by Cox and other big series from the
United States. What do you think is the reason for this difference?
Is it because you are ablating the left side only, or is it because of
the use of radiofrequency, which is well known to be an unreliable
option for the creation of transmural lesion?
With regard to your presentation of ablation lines in the left
atrium, these are basically designed to isolate the pulmonary veins
and are based on the experience of the cardiologists, rather then
solid research. I think that it may be good enough to some extent
for patients with paroxysmal AF, but not for patients with chronic
AF and big atria.
Dr Mohr. I do not believe that this is the final answer to AF in
general. I think that the Cox maze procedure is still the criterion
standard. I do not think that we can yet answer the question of
whether radiofrequency, cryoablation, or microwave is the best
energy source. I think we can say, and I think you will agree, that
we have to have a continuous transmural lesion. We also work
with cryoablation, and the problem is that if you want to do it in
a minimally invasive fashion, almost endoscopically, the cryo-
probe does not allow you to go everywhere you want to, whereas
radiofrequency allows you close contact everywhere, in every
corner, and it is faster. Microwave may allow the same thing. I
think that we all should look into the possibility of a new energy
source that would help us to do it even faster and better.
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The persistent late AF has been looked at by our cardiologists.
It has never come from the right side but has always come from the
left side. They tried to go back with catheter techniques to close the
existing gaps that were present, and I think another reason is the
large left atrium. We have to be more aggressive to downsize the
atria in such patients. We follow Carpentier’s technique to down-
size the left atrium. In those cases in which we reduce the volume,
we also close the left atrial appendage.
Dr D. Craig Miller (Stanford, Calif). How assured are you that
you are getting a full-thickness lesion with these 20-second burns?
Dr Mohr. From the experimental work, we know that with this
probe in 20 seconds we penetrate 1 cm, and within 5 seconds we
reach, at the epicardium, the temperature of 60°C. That is why I
truly believe that the esophageal lesion may have an impact with
this technique. Now that we have isolated it, I hope that we will not
see this problem anymore.
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